{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:35:58Z","timestamp":1789097758312,"version":"build-2803163510"},"reference-count":27,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,11,11]],"date-time":"2009-11-11T00:00:00Z","timestamp":1257897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> Combined treatment with anti\u2010thyroid drugs (ATDs) and potassium iodide (KI) has been used only for severe thyrotoxicosis or as a pretreatment before urgent thyroidectomy in patients with Graves\u2019 disease. We compared methimazole (MMI) treatment with MMI\u2003+\u2003KI treatment in terms of rapid normalization of thyroid hormones during the early phase and examined the later induction of disease remission.<\/jats:p><jats:p><jats:bold>Design and patients\u2002<\/jats:bold> A total of 134 untreated patients with Graves\u2019 disease were randomly assigned to one of four regimens: Group 1, MMI 30\u2003mg; Group 2, MMI 30\u2003mg\u2003+\u2003KI; Group 3, MMI 15\u2003mg and Group 4, MMI 15\u2003mg\u2003+\u2003KI. For easy handling, KI tablets were used instead of saturated solution of KI. KI was discontinued when patients showed normal free thyroxine (FT4) levels but MMI was continued with a tapering dosage until remission. Remission rate was examined during a 4\u2010 to 5\u2010year observation.<\/jats:p><jats:p><jats:bold>Measurements\u2002<\/jats:bold> Serum FT4, FT3 and TSH were measured by chemiluminescent immunoassays. TSH receptor antibody (TRAb) was assayed with TRAb\u2010ELISA. Goitre size was estimated by ultrasonography.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> After 2\u2003weeks of treatment, normal FT4 was observed in 29% of patients in Group 1 and 59% (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b705) of patients in Group 2. Furthermore, normal FT4 after 2\u2003weeks of treatment was observed in 27% of patients in Group 3 and 54% (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b705) of patients in Group 4. Similarly, FT3 normalized more rapidly in Groups 2 and 4 than in Groups 1 and 3. None of the patients showed an increase in thyroid hormones or aggravation of disease during combined treatment with MMI and KI. The remission rates in Groups 1, 2, 3 and 4 were 34%, 44%, 33% and 51%, respectively, and were higher in the groups receiving combined therapy but differences among four groups did not reach significance.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Combined treatment with MMI and KI improved the short\u2010term control of Graves\u2019 hyperthyroidism and was not associated with worsening hyperthyroidism or induction of thionamide resistance.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2009.03745.x","type":"journal-article","created":{"date-parts":[[2009,11,11]],"date-time":"2009-11-11T15:34:11Z","timestamp":1257953651000},"page":"845-850","source":"Crossref","is-referenced-by-count":37,"title":["Benefit of short\u2010term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves\u2019 disease"],"prefix":"10.1111","volume":"72","author":[{"given":"Kazuna","family":"Takata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Amino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumihisa","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eijun","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Fukata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,5,18]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14073-1"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.44.509"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1991.1.129"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(18)30165-8"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107744"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-45-4-623"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1988.tb01217.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-40-1-33"},{"key":"e_1_2_5_10_2","first-page":"1373","article-title":"Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves\u2019 disease","volume":"15","author":"Erbil Y.","year":"2007","journal-title":"Thyroid"},{"key":"e_1_2_5_11_2","doi-asserted-by":"crossref","unstructured":"Kubota S. Ohye H. Sasaki I.et al.(2005)Successful use of iodine and levothyroxine to treat Graves' disease in a pregnant patient with allergy to antithyroid drugs and high thyrotropin\u2010binding inhibitor immunoglobulin after radioiodine therapy.Thyroid 15 1373\u20131376.","DOI":"10.1089\/thy.2005.15.1373"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.50.45"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2006.0245"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.02832.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106225"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198004173021602"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-98-4-1031"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-99-6-1463"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-103-3-871"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03347940"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-61-2-374"},{"key":"e_1_2_5_22_2","first-page":"487","article-title":"Thyrotoxic crisis after exposure to iodine. A case with fatal outcome","volume":"34","author":"Blattmann H.","year":"1994","journal-title":"Radiologe"},{"key":"e_1_2_5_23_2","first-page":"315","article-title":"Effects of propylthiouracil and relatively small doses of iodide on early phase treatment of hyperthyroidism","volume":"93","author":"Kasai K.","year":"1980","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30477-1"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.226.9.1083"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.44.553"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2135"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2008.0364"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2009.03745.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2009.03745.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:34:52Z","timestamp":1697441692000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2009.03745.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,18]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1365-2265.2009.03745.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03745.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,18]]}}}